Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Update: expanded availability of thimerosal preservative-free hepatitis B vaccine.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2000 Jul 21;49(28):642, 651.

2.

Availability of hepatitis B vaccine that does not contain thimerosal as a preservative.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Sep 10;48(35):780-2.

3.

Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Feb 16;50(6):94-7.

5.

Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults.

Van Damme P, von Sonnenburg F, Hatz C, Hoet B, Lefevre I, Leyssen M.

J Med Virol. 2009 Oct;81(10):1710-5. doi: 10.1002/jmv.21568.

PMID:
19697416
6.
7.

Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.

Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G.

Pediatrics. 2003 Jun;111(6 Pt 1):e645-9.

PMID:
12777580
8.

Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Nov 21;57(46):1252-5.

9.

Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations.

Clark SJ, Cabana MD, Malik T, Yusuf H, Freed GL.

Arch Pediatr Adolesc Med. 2001 Aug;155(8):915-20.

PMID:
11483119
10.
11.
12.

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.

Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J.

Pediatrics. 2008 Feb;121(2):e208-14. doi: 10.1542/peds.2006-3363.

PMID:
18245396
13.

[Mercury in vaccines].

Hessel L.

Bull Acad Natl Med. 2003;187(8):1501-10. Review. French.

PMID:
15146581
14.

Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.

Stajich GV, Lopez GP, Harry SW, Sexson WR.

J Pediatr. 2000 May;136(5):679-81.

PMID:
10802503
15.

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC.

J Med Virol. 2001 Jul;64(3):290-8.

PMID:
11424117
16.
17.

FDA approval for a combined hepatitis A and B vaccine.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Sep 21;50(37):806-7.

18.

Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.

Brayden RM, Pearson KA, Jones JS, Renfrew BL, Berman S.

J Pediatr. 2001 May;138(5):752-5.

PMID:
11343056
19.

Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Jul 9;48(26):563-5.

20.

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.

Coates T, Wilson R, Patrick G, André F, Watson V.

Clin Ther. 2001 Mar;23(3):392-403.

PMID:
11318074

Supplemental Content

Support Center